Investigation of the diastereomerism of dihydrobenzoxathiin SERMs for ER alpha by molecular modeling

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

Molecular dynamics simulations were performed to investigate the distinct uterine activity of ten dihydrobenzoxathiin diastereomers against human estrogen receptor (ER) α. These diastereomers share similar binding mode to ER α ligand binding domain (LBD). Dihydrobenzoxathiin diastereomers with full antagonistic activity form more stable hydrogen bonds with Glu353 and His524 of ER α LBD than corresponding diastereomers. The molecular mechanics based generalized born surface area (MM-GBSA) analysis revealed that van der Waals interactions are predominant to the binding of dihydrobenzoxathiin diastereomers to ER α LBD. The per-residue free energy decomposition analysis revealed that the uterine activity difference is contributed mainly by electrostatic interactions. Our study provides mechanistic insights into the difference of uterine activity for dihydrobenzoxathiin diastereomers.

Knowledge Graph

Similar Paper

Investigation of the diastereomerism of dihydrobenzoxathiin SERMs for ER alpha by molecular modeling
Bioorganic & Medicinal Chemistry Letters 2011.0
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators
Journal of Medicinal Chemistry 2004.0
Hydrophobic Interactions Improve Selectivity to ERα for Benzothiophene SERMs
ACS Medicinal Chemistry Letters 2012.0
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains
Bioorganic & Medicinal Chemistry Letters 2004.0
Selective Estrogen Receptor Modulators with Conformationally Restricted Side Chains. Synthesis and Structure−Activity Relationship of ERα-Selective Tetrahydroisoquinoline Ligands
Journal of Medicinal Chemistry 2005.0
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains
Bioorganic & Medicinal Chemistry Letters 2004.0